Anna Borgenvik

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Mainwaring, Oliver; Weishaupt, Holger; Zhao, Miao; Rosén, Gabriela et al.

Ingår i Nature Communications, 2023

• DOI för ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
• Ladda ner fulltext (pdf) av ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Borgenvik, Anna; Holmberg, Karl O.; Bolin, Sara; Zhao, Miao et al.

Ingår i Cancer Research, s. 4586-4603, 2022

• DOI för Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
• Ladda ner fulltext (pdf) av Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Targeting MYCN in Molecularly Defined Malignant Brain Tumors

Borgenvik, Anna; Cancer, Matko; Hutter, Sonja; Swartling, Fredrik J.

Ingår i Frontiers in Oncology, 2021

• DOI för Targeting MYCN in Molecularly Defined Malignant Brain Tumors
• Ladda ner fulltext (pdf) av Targeting MYCN in Molecularly Defined Malignant Brain Tumors

MYC-driven Medulloblastoma: New Targeted Therapies and Mechanisms of Recurrence

Borgenvik, Anna

2021

• Ladda ner fulltext (pdf) av MYC-driven Medulloblastoma: New Targeted Therapies and Mechanisms of Recurrence

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma

Bolin, Sara; Borgenvik, Anna; Persson, Camilla U.; Sundström, Anders et al.

Ingår i Oncogene, s. 2850-2862, 2018

• DOI för Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
• Ladda ner fulltext (pdf) av Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Mainwaring, Oliver; Weishaupt, Holger; Zhao, Miao; Rosén, Gabriela et al.

Ingår i Nature Communications, 2023

• DOI för ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
• Ladda ner fulltext (pdf) av ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors

Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Borgenvik, Anna; Holmberg, Karl O.; Bolin, Sara; Zhao, Miao et al.

Ingår i Cancer Research, s. 4586-4603, 2022

• DOI för Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma
• Ladda ner fulltext (pdf) av Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma

Bolin, Sara; Borgenvik, Anna; Persson, Camilla U.; Sundström, Anders et al.

Ingår i Oncogene, s. 2850-2862, 2018

• DOI för Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma
• Ladda ner fulltext (pdf) av Combined BET bromodomain and CDK2 inhibition in MYC-driven medulloblastoma

Dormant SOX9-positive cells behind MYC-driven medulloblastoma recurrence

Bolin, Sara; Borgenvik, Anna; Savov, Vasil; Holmberg Olausson, Karl et al.

Targeting MYCN in Molecularly Defined Malignant Brain Tumors

Borgenvik, Anna; Cancer, Matko; Hutter, Sonja; Swartling, Fredrik J.

Ingår i Frontiers in Oncology, 2021

• DOI för Targeting MYCN in Molecularly Defined Malignant Brain Tumors
• Ladda ner fulltext (pdf) av Targeting MYCN in Molecularly Defined Malignant Brain Tumors

MYC-driven Medulloblastoma: New Targeted Therapies and Mechanisms of Recurrence

Borgenvik, Anna

2021

• Ladda ner fulltext (pdf) av MYC-driven Medulloblastoma: New Targeted Therapies and Mechanisms of Recurrence

CDK2 as a therapeutic target in MYC-driven medulloblastoma

Borgenvik, Anna; Rosén, Gabriela; Holmberg Olausson, Karl; Larsson, Lars-Gunnar et al.